Gary P. Moran

Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro

Gary P. Moran, Derek J. Sullivan, Martin Henman et al. · Antimicrobial Agents and Chemotherapy · 1997 · 274 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Comparative genomics of the fungal pathogens <i>Candida dubliniensis</i> and <i>Candida albicans</i>

Andrew P. Jackson, John Gamble, Tim Yeomans et al. · Genome Research · 2009 · 218 citations · Full text

Life Sciences, Genetics, Microbiology +17

Identification and Expression of Multidrug Transporters Responsible for Fluconazole Resistance in <i>Candida dubliniensis</i>

Gary P. Moran, Dominique Sanglard, Samantha Donnelly et al. · Antimicrobial Agents and Chemotherapy · 1998 · 194 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

The Microbiome of Potentially Malignant Oral Leukoplakia Exhibits Enrichment for Fusobacterium, Leptotrichia, Campylobacter, and Rothia Species

Abdrazak Amer, Sheila Galvin, Claire M. Healy et al. · Frontiers in Microbiology · 2017 · 194 citations · Full text

Dentistry, Microbiology, Oral Biology +17

Bacteriology of Skin and Soft-Tissue Infections: Comparison of Infections in Intravenous Drug Users and Individuals with No History of Intravenous Drug Use

Paula Summanen, David A. Talan, C A Strong et al. · Clinical Infectious Diseases · 1995 · 178 citations

Life Sciences, Infectious Diseases, Microbiology +16